Maintaining cellular proteostasis is essential for oligodendrocyte viability and function; however, its underlying mechanisms remain unexplored. The UPR, comprising three parallel branches IRE1, PERK, and ATF6a, is a major mechanism that maintains cellular proteostasis by facilitating protein folding, attenuating protein translation, and enhancing autophagy and ERAD. Here we reported that impaired UPR in oligodendrocytes via deletion of PERK and ATF6a did not affect developmental myelination, but caused lateonset mature oligodendrocyte dysfunction and death in young adult mice. The detrimental effects of the impaired UPR on mature oligodendrocytes were accompanied by autophagy impairment and intracellular PLP accumulation, and were rescued by PLP deletion. Data indicate that PLP is degraded by autophagy and that intracellular PLP accumulation is cytotoxic to oligodendrocytes. Thus, these findings imply that the UPR is required for maintaining cellular proteostasis and the viability and function of mature oligodendrocytes in adults by regulating autophagy of PLP.
Introduction
The endoplasmic reticulum (ER) is the site in eukaryotic cells in which modification and folding of membrane and secretory proteins takes place (1, 2) . Properly folded proteins are transported to their destinations through the cellular secretory pathway. Perturbations in protein modification or folding lead to accumulation of unfolded or misfolded proteins in the ER, and result in ER stress and activation of the unfolded protein response (UPR), which comprises three parallel branches: inositol requiring enzyme 1 (IRE1), pancreatic ER kinase (PERK), and activating transcription factor 6α (ATF6α) (3) (4) (5) . IRE1 activation increases the expression of genes that enhance protein folding and protein degradation by splicing X-box binding protein 1 (XBP1) mRNA. PERK activation inhibits protein translation but stimulates the expression of genes related to macroautophagy (a bulk protein degradation process, hereafter referred to as autophagy) and genes related to ER-associated degradation (ERAD) by phosphorylating eukaryotic translation initiation factor 2 (eIF2α). ATF6α activation enhances the expression of ER chaperones, autophagy-related genes, and ERAD-related genes. The UPR is a major mechanism that maintains ER protein homeostasis and a major component of the cellular proteostasis network that preserves cellular proteostasis (4, 6, 7) .
Myelin is an enormous membrane structure that wraps and insulates axons. Oligodendrocytes, the myelin-producing cells in the central nervous system (CNS), must produce a vast amount of membrane proteins via the ER to assemble and maintain the structure of myelin sheaths (2, 8, 9) .
The current dogma is that maintaining ER protein homeostasis is essential for the production of myelin proteins and the myelinating function of oligodendrocytes (2, 10, 11) . It is well documented that oligodendrocytes are highly sensitive to disruption of ER protein homeostasis and that this increased susceptibility contributes to the pathogenesis of various myelin disorders (2, (10) (11) (12) . A number of studies have demonstrated that the PERK branch of the UPR is a major player in regulating the viability and function of oligodendrocytes in myelin disorders (13) (14) (15) . A recent study also suggests the cytoprotective effects of the ATF6α branch on oligodendrocytes in immune-mediated demyelinating diseases (16) . Nevertheless, it remains unknown whether the UPR is involved in maintaining ER protein homeostasis and cellular proteostasis in oligodendrocytes, or their viability and function, under physiological conditions. While the IRE1 branch is regarded as the most conserved branch of the UPR, there is no evidence that this branch plays a major role in oligodendrocytes (12, 17, 18) . Conversely, evidence suggests that PERK and ATF6α are activated in oligodendrocytes under normal and disease conditions (12, 18, 19) . However, deletion of either PERK or ATF6α has no effect on oligodendrocytes in mice under physiological conditions (15, 16) . The minimal effect of PERK deletion or ATF6α deletion on oligodendrocytes is likely due to the functional redundancy of these two branches, as both of them enhance autophagy and ERAD. Thus, in this study, we determined the physiological role of the UPR in oligodendrocytes by generating a mouse model that allows for inactivation of both PERK and ATF6α in oligodendrocytes. Intriguingly, we found that inactivation of PERK and ATF6α in oligodendrocytes led to late-onset demyelination in the CNS of young adult mice. We also found that inactivation of PERK and ATF6α caused impairment of the autophagy-lysosome pathway and soma retention of proteolipid protein (PLP) in mature oligodendrocytes of young adult mice. It is known that soma retention of PLP in oligodendrocytes is a major contributor to dysmyelination or late-onset demyelination in the CNS in Pelizaeus-Merzbacher disease (PMD) patients and its animal models that carry increased copies of Plp1 gene, and that the autophagylysosome pathway is one of the major mechanisms responsible for PLP degradation in oligodendrocytes (20) (21) (22) (23) . Importantly, we showed that PLP deficiency attenuated myelin abnormalities in the CNS of young adult mice with double deletion of PERK and ATF6α in oligodendrocytes. Collectively, our results suggest that impaired UPR leads to impairment of the autophagy-lysosome pathway and soma retention of PLP in mature oligodendrocytes, resulting in late-onset demyelination in the CNS of young adult mice.
Results

Inactivation of PERK and ATF6α in oligodendrocytes caused late-onset demyelination in young adult mice
Active developmental myelination occurs in the rodent CNS between postnatal day (P) 7 and P 21 (24) . Currently available data indicate that actively myelinating oligodendrocytes during this stage have a much higher rate of myelin protein production and are more susceptible to disruption of ER protein homeostasis than mature oligodendrocytes in adults (2, 8, 10) . Several studies showed that ATF6α homozygous knock-out (ATF6α KO) mice appear healthy and exhibit normal myelination in the CNS (16, 25) . A previous study demonstrated that PERK is deleted specifically in oligodendrocytes in the CNS of PERK loxP/loxP ; CNP/Cre (PERK KO) mice, and that PERK inactivation has no effect on oligodendrocytes or myelin in these mice (15) . To determine the physiological role of the UPR in oligodendrocytes, we crossed ATF6α KO mice with PERK KO mice to generate mice with double deletion of PERK and ATF6α in oligodendrocytes (Double KO mice), PERK KO mice, ATF6α KO mice, and corresponding control mice (WT mice). We performed real-time PCR to verify the deletion of PERK and ATF6α in oligodendrocytes of Double KO mice using the optic nerve, since approximately 60% of cells in the optic nerve are oligodendrocytes (26, 27) . As expected, we found that the mRNA levels of PERK and ATF6α were significantly reduced in the optic nerve of Double KO mice compared to WT mice ( Figure   1A ). Moreover, we determined whether inactivation of PERK and ATF6α disrupts ER protein homeostasis in oligodendrocytes in young developing and/or adult mice. RT-PCR analysis showed that the spliced XBP1 (XBP1s) mRNA was undetectable in the spinal cord of WT mice, PERK KO mice, and ATF6α KO mice, but became moderately detectable in Double KO mice at P 21 and P 45 ( Figure 1B , C). Moderate splicing of XBP1 mRNA suggests moderate disruption of ER protein homeostasis and modest activation of ER stress in oligodendrocytes of Double KO mice.
Thus, these results suggest that inactivation of PERK and ATF6α moderately disrupts ER protein homeostasis in both actively myelinating oligodendrocytes in young developing mice and in mature oligodendrocytes in young adult mice.
As expected, both PERK KO mice and ATF6α KO mice looked healthy and survived well.
Surprisingly, Double KO mice were asymptomatic and their body weight was comparable to WT mice, PERK KO mice, and ATF6α KO mice during the active developmental myelination stage.
Interestingly, Double KO mice gained body weight at a reduced rate compared to WT mice, PERK KO mice, and ATF6α KO mice starting at P 23 ( Figure 1D ), and displayed a tremoring phenotype starting around P 28. All Double KO mice showed severe tremor by P 45 and died by P 65 ( Figure   1E ). Similarly, Rotarod test showed that Double KO mice displayed normal motor coordination compared to WT mice, PERK KO mice, and ATF6α KO mice before P 28; however, motor coordination of Double KO mice gradually declined after P 28, and became severely impaired after P 35 ( Figure 1F ). These results demonstrate that inactivation of PERK and ATF6α in oligodendrocytes induces a late-onset and progressive tremoring phenotype in mice.
A late-onset tremoring phenotype displayed by Double KO mice implies myelin abnormalities in the CNS of these mice. We first determined whether inactivation of PERK and ATF6α in oligodendrocytes affects developmental myelination. Myelin basic protein (MBP) immunohistochemistry (IHC), CC1 (an oligodendrocyte marker) IHC, and electron microscopy (EM) analysis showed a comparable degree of myelination and a comparable number of oligodendrocytes in the CNS of WT mice, PERK KO mice, and ATF6α KO mice at P 21 ( Figure  2A -C, E-G, I-K, Q-T, Supplemental Figure 1 ). Unexpectedly, MBP IHC showed that inactivation of PERK and ATF6α in oligodendrocytes did not alter the degree of myelination in the CNS at P 21 ( Figure 2A -D, Supplemental Figure 1 ). EM analysis confirmed that inactivation of PERK and ATF6α in oligodendrocytes did not alter the percentage of myelinated axons, the thickness of myelin, or the g-ratio in the CNS at P 21 ( Figure 2E -H, Q-S). CC1 IHC showed that inactivation of PERK and ATF6α in oligodendrocytes did not change oligodendrocyte numbers in the CNS at P 21 ( Figure 2I -L, T, Supplemental Figure 1 ). Moreover, EM analysis showed that both the morphology of oligodendrocytes and the morphology of the ER in these cells in Double KO mice were indistinguishable from those of WT mice, PERK KO mice, and ATF6α KO mice at P 21 ( Figure 2M -P). Taken together, these data suggest that the inactivation of PERK and ATF6α has a minimal effect on the viability and function of actively myelinating oligodendrocytes during developmental myelination.
We further determined whether inactivation of PERK and ATF6α in oligodendrocytes leads to late-onset demyelination in the CNS. MBP IHC, CC1 IHC, and EM analysis showed that the degree of myelination and the number of oligodendrocytes were comparable in the CNS of WT mice, PERK KO mice, and ATF6α KO mice at P 45 ( Figure 3A suggesting that the enlarged soma of oligodendrocytes results from the accumulation of autophagic vacuoles in these cells. Thus, these data demonstrate that inactivation of PERK and ATF6α leads to dysfunction and death of mature oligodendrocytes in young adult mice.
It is known that the promoter of the 2',3' cyclic nucleotide 3' phosphodiesterase (CNP) gene drives Cre recombinase expression in both oligodendrocytes in the CNS and in Schwann cells in the PNS in CNP/Cre mice starting at early developmental myelination (28, 29) . Next, we assessed myelin integrity in the PNS of Double KO mice. Real-time PCR analysis confirmed that the mRNA levels of PERK and ATF6α were significantly reduced in the sciatic nerve of Double KO mice compared to WT mice ( Figure 5A ). RT-PCR analysis showed that the XBP1s mRNA was undetectable in the sciatic nerve of WT mice, PERK KO mice, and ATF6α KO mice, but became modestly detectable in Double KO mice at P 21 and P 45 ( Figure 5B , C). Nevertheless, toluidine blue staining showed that the degree of myelination in the sciatic nerve of Double KO mice was comparable to WT mice, PERK KO mice, and ATF6α KO mice at P 21 and P 45 ( Figure 5D -K).
Thus, these data demonstrate that inactivation of PERK and ATF6α modestly disrupts ER protein homeostasis in Schwann cells, but does not affect their viability or function under normal conditions.
Inactivation of PERK and ATF6α led to impairment of the autophagy-lysosome pathway in mature oligodendrocytes of young adult mice
Evidence suggests that inactivation of PERK or ATF6α causes autophagy defects in ER-stressed cells (30) (31) (32) . Accumulation of autophagic vacuoles in mature oligodendrocytes of 45-day-old Double KO mice indicates that inactivation of PERK and ATF6α causes defects in the autophagylysosome pathway in these cells. It is known that defects of autophagic flux causes intracellular accumulation of p62 (SQSTM1, sequestosome-1) and ubiquitinated proteins (33) (34) (35) . p62 (an autophagic cargo adaptor) can bind to ubiquitinated proteins as well as autophagosome membrane proteins, and deliver ubiquitinated protein aggregates for autophagy (36) . p62 itself is also degraded by autophagy. Ubiquitin and aspartoacylase (ASPA, an oligodendrocyte marker) double immunostaining showed that the immunoreactivity of ubiquitin was barely detectable in oligodendrocytes of 21 or 45-day-old WT mice, PERK KO mice, and ATF6α KO mice ( Figure   6A -C, E-G). Similarly, p62 and ASPA double immunostaining showed that the immunoreactivity of p62 was barely detectable in oligodendrocytes of 21 or 45-day-old WT mice, PERK KO mice, and ATF6α KO mice ( Figure 6J -L, N-P). There was no accumulation of ubiquitinated proteins or p62 in oligodendrocytes of 21-day-old Double KO mice ( Figure 6A -D, J-M). Importantly, ubiquitin and ASPA double immunostaining showed that the immunoreactivity of ubiquitin was markedly increased in oligodendrocytes in the CNS of 45-day-old Double KO mice compared to WT mice, PERK KO mice, and ATF6α KO mice ( Figure 6E -I). Similarly, p62 and ASPA double immunostaining showed that the immunoreactivity of p62 was markedly increased in oligodendrocytes in the CNS of 45-day-old Double KO mice compared to WT mice, PERK KO mice, and ATF6α KO mice ( Figure 6N Data indicate that activation of PERK or ATF6α enhances the expression of genes related to the autophagy-lysosome pathway (37) (38) (39) . To identify the genes involved in impairment of autophagic flux in mature oligodendrocytes of Double KO mice, we employed an unbiased, whole-genome RNA-sequencing approach using the RNA isolated from the optic nerve of 28-day-old Double KO mice and WT mice. We performed differential gene expression analysis and analyzed the expression of genes related to the autophagy-lysosome pathway. Among 664 significantly downregulated genes in the optic nerve of Double KO mice, we found two genes related to the autophagy-lysosome pathway, SEZ6L2 (Seizure Related 6 Homolog Like 2) and GNPTAB (encoding the alpha and beta subunits of GlcNAc-1-phosphotransferase) (data not shown).
Interestingly, both SEZ6L2 and GNPTAB participate in the transport of the lysosomal hydrolase cathepsin D from the trans-Golgi network to the lysosome (40) (41) (42) (43) . Importantly, real-time PCR analysis confirmed that the mRNA levels of SEZ6L2 were significantly decreased in the optic nerve of Double KO mice compared to WT mice, PERK KO mice, and ATF6α KO mice at P 28 and P 45, but not at P 21 ( Figure 7A -C). Furthermore, the mRNA levels of GNPTAB were significantly decreased in the optic nerve of Double KO mice compared to WT mice, PERK KO mice, and ATF6α KO mice at P 28, and in the optic nerve of Double KO mice compared to WT mice and PERK KO mice P 45, but were not decreased at P 21. We further assessed the subcellular localization of cathepsin D in oligodendrocytes of these mice. As expected, CC1, LAMP1 (lysosomal-associated membrane protein 1), and cathepsin D triple immunostaining showed that a substantial amount of cathepsin D was co-localized with the lysosome marker LAMP1 in CC1positive oligodendrocytes of 45-day-old WT mice, PERK KO mice, and ATF6α KO mice ( Figure   7D -R). In contrast, the amount of cathepsin D that was co-localized with LAMP1 in mature oligodendrocytes of 45-day-old Double KO mice was minimal ( Figure 7S -W). These results suggest that the attenuated expression of SEZ612 and GNPTAB disrupts the transport of cathepsin D from the trans-Golgi network to the lysosome, and results in mislocalization of cathepsin D in mature oligodendrocytes of young adult Double KO mice. Cathepsin D is a major lysosomal protease responsible for degradation of proteins delivered to the lysosomes via autophagy (41, 44) .
It is well documented that inactivation or mislocalization of cathepsin D causes lysosome dysfunction and impairment of autophagic flux (44) (45) (46) . Taken together, these data suggest that inactivation of PERK and ATF6α leads to delocalization of cathepsin D from the lysosome by attenuating the expression of SEZ6L2 and GNPTAB, and subsequently results in impairment of the autophagy-lysosome pathway in mature oligodendrocytes of young adult mice.
Inactivation of PERK and ATF6α led to soma retention of PLP in mature oligodendrocytes of young adult mice
PLP, the most abundant myelin protein in the CNS, is synthesized in the ER and transported to myelin sheaths (21) . The autophagy-lysosome pathway is one of major mechanism responsible for PLP degradation in oligodendrocytes (20, 22) . It is well documented that overexpression of PLP induced by increased copies of the Plp1 gene causes accumulation of this protein in the soma of oligodendrocytes and results in dysmyelination or late-onset demyelination in the CNS of human PMD patients and its animal models (20) (21) (22) (23) . Interestingly, a number of studies showed that overexpression of PLP leads to accumulation of this protein in autophagic vacuoles in oligodendrocytes of mice carrying increased copies of the Plp1 gene (20, 22, 47) . We showed here that inactivation of PERK and ATF6α led to impairment of autophagic flux in mature oligodendrocytes and late-onset demyelination in young adult mice. Thus, these data raise the possibility that inactivation of PERK and ATF6α attenuates PLP degradation through impairment of the autophagy-lysosome pathway, resulting in soma retention of PLP in mature oligodendrocytes and subsequent late-onset demyelination in the CNS of young adult mice.
We first determine whether inactivation of PERK and ATF6α leads to soma retention of PLP in oligodendrocytes. PLP and ASPA double immunostaining showed strong PLP immunoreactivity in myelinating tracts and little PLP immunoreactivity in the soma of oligodendrocytes in the CNS of 21 or 45-day-old WT mice, PERK KO mice, and ATF6α KO mice ( Figure 8A Figure 1E ).
As expected, MBP IHC, CC1 IHC, and EM analysis showed that PLP deficiency alone did not significantly alter the degree of myelination or the number and morphology of oligodendrocytes, but caused mild axon degeneration in the CNS at P 45 ( Figure 3A 
Discussion
In order to assemble the myelin sheaths, actively myelinating oligodendrocytes must produce vast amounts of myelin proteins via the ER during developmental myelination. Mature oligodendrocytes in adults must also produce large amounts of myelin proteins via the ER to maintain myelin structure. It was thought that actively myelinating oligodendrocytes are more sensitive to disruption of ER protein homeostasis than mature oligodendrocytes, due to the rate of production of myelin proteins (2, 8, 10) . The UPR is a major mechanism that maintains ER protein homeostasis and cellular proteostasis (3, 4, 6, 7) . As expected, we found that the impaired UPR in oligodendrocytes via inactivation of PERK and ATF6α induced moderate disruption of ER protein homeostasis in these cells, as evidenced by moderate XBP1 mRNA splicing and the normal morphology of the ER in oligodendrocytes in the CNS of Double KO mice. Surprisingly, inactivation of PERK and ATF6α in oligodendrocytes did not affect the viability or function of actively myelinating oligodendrocytes during developmental myelination, but led to late-onset mature oligodendrocyte dysfunction and death in young adult mice. Thus, these data suggest that the UPR is not a major player in regulating ER protein homeostasis or cellular proteostasis in actively myelinating oligodendrocytes, or in maintaining their viability and function during developmental myelination.
Cathepsin D, a ubiquitously expressed aspartic-type protease, is a major lysosomal protease responsible for degradation of proteins delivered to the lysosomes via autophagy (41, 44) .
Inactivation or mislocalization of cathepsin D causes lysosome dysfunction and accumulation of autophagic vacuoles in cells (44) (45) (46) . Cathepsin D is synthesized in the ER and transported to the lysosome via the trans-Golgi network through the mannose 6-phosphate (M6P)-dependent pathway and M6P-independent pathways (41, 42, 51) . GlcNAc-1-phosphotransferase catalyzes the synthesis of the M6P residues on cathepsin D in the trans-Golgi network, this allows cathepsin D to be recognized by M6P receptors (MPRs), which initiate the protease packaging into clathrincoated vesicles that travel to pre-lysosomal compartments (40, 43, 51) . Moreover, data indicate that SEZ6L2 participates in the trafficking of cathepsin D to pre-lysosomal compartments via a M6P-independent pathway (42) . Deficiency of either GNPTAB (encoding the alpha and beta subunits of GlcNAc-1-phosphotransferase) or SEZ6L2 leads to delocalization of cathepsin D from the lysosome in cells (40, 42, 43) . Interestingly, we showed here that inactivation of PERK and A very recent study suggest that autophagy is an important player in regulating oligodendrocyte viability and function (52) . Evidence suggests that autophagy is one of the major mechanisms responsible for degradation of PLP (20, 22) . Several studies showed that cathepsin D deficiency causes dysmyelination in the CNS of mice, accompanied with intracellular PLP accumulation and co-localization of PLP with LAMP1 (a lysosome marker) in oligodendrocytes (53, 54) . Herein, we showed that inactivation of PERK and ATF6α led to intracellular PLP accumulation and colocalization of PLP with ubiquitin, p62, and LAMP1 in mature oligodendrocytes of young adult mice. Moreover, previous reports showed that overexpression of PLP induced by increased copies of the Plp1 gene leads to accumulation of this protein in autophagic vacuoles in oligodendrocytes of mice (20, 22) . Thus, these data suggest that inactivation of PERK and ATF6α attenuates autophagy-mediated PLP degradation by impairing cathepsin D activity in the lysosomes, and results in PLP accumulation in autophagic vacuoles in mature oligodendrocytes of young adult mice.
It is believed that that overexpression of PLP induced by increased copies of the Plp1 gene causes intracellular PLP accumulation in oligodendrocytes and subsequently results in dysmyelination or late-onset demyelination in human PMD and its animal models, although the mechanisms responsible for the cytotoxic effects of intracellular PLP accumulation on oligodendrocytes remain unknown (20) (21) (22) (23) . Moreover, a number of studies showed that PLP is accumulated in autophagic vacuoles in oligodendrocytes of mice that carry increased copies of the Plp1 gene (20, 22, 47) .
Thus, we tested the possibility that PLP accumulation in autophagic vacuoles in oligodendrocytes contributes to the late-onset demyelination in young adult Double KO mice. We crossed Double KO mice with PLP KO mice to obtain mice with deletion of PERK, ATF6α, and PLP in oligodendrocytes (Triple KO mice). Importantly, we showed that PLP deficiency significantly Data indicate that endocytic sorting and recycling of PLP is involved in myelin sheath assembly and remodeling (57). There is evidence that PLP is also accumulated in the late endosomes/endolysosome in oligodendrocytes of mice carrying increased copies of the Plp1 gene (58). Interestingly, a previous report showed that feeding these mice a high cholesterol diet reduces PLP accumulation in the late endosomes/endolysosome by facilitating incorporation of PLP into myelin sheaths, and prevents disease progression (59). To explore the possibility of accumulation of PLP in the late endosomes/endolysosome of mature oligodendrocytes in Double KO mice, we fed these mice the high cholesterol diet as described in the previous report (59). Nevertheless, we found that high cholesterol treatment did not affect the disease progression or lifespan of Double KO mice (Supplemental Figure 4) . Thus, it is unlikely that inactivation of PERK and ATF6α induces PLP accumulation in the late endosomes/endolyososome in mature oligodendrocytes of young adult mice.
Paradoxically, there was no evidence that inactivation of PERK and ATF6α led to impairment of autophagic flux or intracellular PLP accumulation in actively myelinating oligodendrocytes during developmental myelination. These data suggest that the role of the UPR in regulating lysosome function, autophagic flux, and PLP homeostasis in oligodendrocytes is dependent on the differentiation stages of the cells. It is unclear how the UPR is required for maintaining cellular proteostasis in mature oligodendrocyte of young adult mice, but not in actively myelinating oligodendrocytes of young developing mice. Additionally, we showed here that inactivation of PERK and ATF6α had no effect on Schwann cells in young developing or adult mice, suggesting that the UPR is not a major player in maintaining ER protein homeostasis or cellular proteostasis in Schwann cells. Clearly, the mechanisms by which actively myelinating oligodendrocytes and Schwann cells maintain their ER protein homeostasis and/or cellular proteostasis warrant further investigation.
In summary, we showed here that inactivation of PERK and ATF6α in oligodendrocytes had a minimal effect on actively myelinating oligodendrocytes during developmental myelination, but led to late-onset mature oligodendrocyte dysfunction and death in young adult mice by inducing intracellular accumulation of PLP through impairment of the autophagy-lysosome pathway. These findings imply that the UPR is required for maintaining cellular proteostasis and the viability and function of mature oligodendrocytes in adults by regulating autophagy of PLP.
Materials and Methods
Mice. ATF6α homozygous knock-out (ATF6α-/-) mice (25) , PERK loxP mice (60) (The Jackson Laboratory stock #023066), CNP/Cre mice (28) , and PLP heterozygous knock-out (PLP+/-) mice (48) were on the C57BL/6J background. All mice were specific pathogen free and maintained on a 12 hour light/dark cycle. PERK loxP mice were crossed with ATF6α-/-mice to obtain PERK loxP ; ATF6α+/-mice, which were then crossed with CNP/Cre mice to obtain PERK loxP ; CNP/Cre; from DNA extracted from tail tips as described in previous papers (25, 28, 48, 60) . Both male and female mice were used in this study as no sex-based differences were observed.
Rotarod test. The Rotarod apparatus (Panlab/Harvard Apparatus, Barcelona, Spain) with a spindle diameter of 3 cm was used to test motor coordination in mice. Mice were trained by placing them on the Rotarod at a constant speed (4 rpm) for 60 seconds a day before test. For the trials, mice were placed on the Rotarod at 4 rpm, and then the Rotarod was set to accelerate continuously from 4-40 rpm over a period of 300 seconds and the latency to fall was recorded (falls were detected with a pressure sensitive lever). Trials were repeated 3 times/day and the time of the fall was averaged. 300 seconds was the maximum time for the trial, mice that reached this were recorded as 300 seconds and removed from the Rotarod. as described in our previous papers (13, 16, 29) . PCR for X-box binding protein 1 (XBP1) was performed to detect spliced XBP1 (XBP1s) mRNA using Taq DNA Polymerase (Qiagen). PCR products were separated by electrophoresis on a 3% agarose gel as described in our previous paper (16) . Biotechnology, catalog sc-73336) were performed as described in previous papers (16, 29) .
Real
Fluorescent stained sections were mounted with Vectashield mounting medium with DAPI (Vector Laboratories) and visualized with a Zeiss Axioskop 2 fluorescence microscope or an Olympus FV1000 confocal microscope. Whole brain sections were scanned by a TissueScope LE120 slide scanner (Huron Digital Pathology, St. Jacobs, Ontario, Canada). Immunopositive cells in the CNS were quantified as described in our previous papers (14, 16, 27, 29) .
Toluidine blue staining and electron microscopy (EM) analysis.
Mice were anaesthetized and perfused with PBS containing 4% paraformaldehyde and 2.5% glutaraldehyde. The sciatic nerve and cervical spinal cord were processed and embedded as previously described (13, 16, 27, 29) . 1 μm thick sections were cut, stained with toluidine blue, visualized with a Nikon C2 upright confocal microscope, and analyzed as described previously (13, 16, 27, 19) . Ultrathin sections were cut, stained with uranyl acetate and lead citrate, and analyzed as described previously (13, 16, 27, 29) . We counted the total number of axons, the number of degenerating axons, the number of healthy-looking axons, the number of myelinated axons, and calculated the percentage of myelinated axons as described previously (13, 16, 27, 29) . Additionally, the diameter of axon as well as the diameter of axon and myelin were measured and the g-ratio was calculated as diameter of axon/diameter of axon and myelin as described previously (14, 16, 27) .
Statistics. The sample size for each individual experiment is listed in the corresponding figure legend. Data are expressed as mean ± standard deviation (SD). Comparisons between two groups was statistically evaluated by t-test using GraphPad Prism 6 (GraphPad Software RRID:SCR_002798). Multiple comparisons were statistically evaluated by a 1-way ANOVA with a Tukeys posttest or a 2-way ANOVA with a Tukeys posttest using GraphPad Prism 6. P values less than 0.05 were considered significant.
Study approval
All animal procedures were conducted in complete compliance with the NIH Guide for the Care Statistical analyses were done with a 1-way ANOVA with a Tukeys posttest,  P < 0.05. 
